^

News and Publications

Public comment on esophageal cancer guideline, ASTRO 2022 FAQs, First in state accreditation

September 22, 2022

ASTRO 2022 attendee tools: FAQs for attendees, Annual Meeting Guide available
Have questions about the 2022 ASTRO Annual Meeting? Refer to the ASTRO Annual Meeting FAQs to find answers on topics ranging from general conference questions along with important information on safety, programming and presenters. And, be sure to check your inbox for the digital edition of the ASTROnews Annual Meeting Guide, sent Monday, September 19. This special issue of ASTROnews highlights key sessions and features of the meeting, including stories on the ASTRO award recipients. Also included are all the details you need to curate your Annual Meeting experience, whether you attend virtually or in person.
 
Register for the ROI 5k
Get your running (or walking!) shoes ready to join hundreds of your colleagues for a fun event during the ASTRO Annual Meeting! Whether you challenge yourself or join a team, you'll enjoy a beautiful morning along the San Antonio River Walk. The 5k begins at 7:00 a.m., Tuesday, October 25, just three blocks from the convention center and winds along the River Walk. All funds raised will benefit the Radiation Oncology Institute (ROI), ASTRO's research foundation. Register now.
 
Attend ASTRO 2022 from the comfort of your home or office
We know not everyone can travel to San Antonio to attend the in-person ASTRO Annual Meeting, so we’re offering the next best option — the Live Virtual ASTRO Annual Meeting. The Virtual Meeting includes real-time access to the education and scientific sessions and the PRO weekend programming streamed live from San Antonio. The live virtual platform allows you to interact with presenters the same as if you were attending in person using Social Q&A, and you can also apply for CME credit. Narrated posters will be available in the virtual poster library — all this, plus, onDemand access after the meeting! Of course, we hope to see you in San Antonio, but if you can’t join us in person, be sure to register for the Live Virtual ASTRO Annual Meeting.
 
Public comment open on ASTRO guideline on multidisciplinary management of esophageal cancer
ASTRO members are invited to submit comments on the draft clinical practice guidelines on multimodality therapy for locally advanced cancer of the esophagus or gastroesophageal junction. Currently, there are no comprehensive guidelines addressing multidisciplinary management of esophageal cancer that have incorporated the input of surgeons, radiation oncologists and medical oncologists. The draft guideline is a collaboration among the Society of Thoracic Surgeons, ASTRO and ASCO. The guideline addresses key clinical questions pertinent to the care of patients with locally advanced, resectable, thoracic esophageal cancer, including decisions regarding neoadjuvant or definitive chemoradiation, approach and timing of surgery, and adjuvant therapy. Review and submit your comments by Wednesday, October 12.
 
Apply for new guideline task force for postmastectomy radiation therapy
ASTRO will soon begin initiating a task force to update the Postmastectomy Radiation Therapy guideline. To facilitate identifying a diverse task force, ASTRO has implemented a new process for interested members to apply to participate on guidelines task forces. If interested, please apply for consideration. Help spread the word; forward this information if you know of any colleagues that may be interested in this important topic area. The application deadline is Monday, October 17.
   
Listen to the latest podcasts from Red Journal and PRO
From the latest Red Journal podcasts, Editor-in-Chief Sue Yom, MD, PhD, MAS, FASTRO, speaks with Brian Bauman, MD, and James Yu, MD, on reimbursement and the application of alternative payment models to radiation oncology. Dr. Yom also speaks with Jeffrey Olsen, MD, Nima Nabavizadeh, MD, and Michael Buckstein, MD, on indications for EBRT/SBRT for hepatocellular carcinoma in the contemporary context of collaborating and competing liver-directed therapies. Recent podcasts from Practical Radiation Oncology (PRO) feature Editor-in-Chief Robert Amdur, MD, reviewing a Topic Discussion paper on mucosal squamous cell carcinoma from the September/October issue of PRO.
 
Intermountain Medical Center is the first in Utah to earn APEx accreditation
Congratulations to the Intermountain Medical Center for being the first practice in Utah to achieve accreditation through ASTRO’s APEx - Accreditation Program for Excellence®. Intermountain Medical Center has demonstrated they have policies and procedures that promote effective communication, coordinated treatment and willingness to engage patients and their families as partners in care. View a list of accredited facilities and contact ASTRO staff to learn about the new options for accreditation and why APEx is The Right Choice™ to accredit your radiation oncology practice.